1. Inflammatory Markers and the Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
   Bin Su et al, 2016, PLOS ONE CrossRef
2. Beneficial Immunomodulatory Effects of Fluticasone Propionate in Chlamydia pneumoniae-Infected Mice
   Dóra Paróczai et al, 2021, Pathogens CrossRef
3. “Yiqi Huayu, Wenyang Lishui” Prescription (YHWLP) Improves the Symptoms of Chronic Obstructive Pulmonary Disease-Induced Chronic Pulmonary Heart Disease by Inhibiting the RhoA/ROCK Signaling Pathway
   Hui Huang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
4. Evaluation of IL-8 Nasal Lavage Levels and the Effects of Nasal Involvement on Disease Severity in Patients with Stable Chronic Obstructive Pulmonary Disease
   Hacer Celik et al, 2015, Inflammation CrossRef
5. Activity ofα1-Antitrypsin and Some Lysosomal Enzymes in the Blood Serum of Patients with Chronic Obstructive Pulmonary Disease after Smoking Cessation
   Bartosz Woźniak et al, 2015, BioMed Research International CrossRef
6. Targeting Molecular and Cellular Mechanisms in Chronic Obstructive Pulmonary Disease
   Shvetank Bhatt et al, 2021, Targeting Cellular Signalling Pathways in Lung Diseases CrossRef
7. Lymphotoxin β Receptor Signaling Induces IL-8 Production in Human Bronchial Epithelial Cells
   Yu Mikami et al, 2014, PLoS ONE CrossRef
8. Inhaled β2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?
   Krishna Sriram et al, 2021, Pharmacological Reviews CrossRef